Abstract. Castration-resistant prostate cancer (PCa) almost invariably occurs after androgen deprivation therapy for metastatic disease and is driven in part b
Toni Choueiri: Honored by the King Hussein Cancer Foundation / cancer, Dana-Farber Cancer Institute, DFCI, HRH Princess Ghida Talal, King Hussein Cancer
Toni Choueiri: Honored by the King Hussein Cancer Foundation / cancer, Dana-Farber Cancer Institute, DFCI, HRH Princess Ghida Talal, King Hussein Cancer
“When I meet patients who tell me: ‘You saved my life,’ it is an unforgettable moment.” Read about laureates James P. Allison and Tasuku Honjo…
“When I meet patients who tell me: ‘You saved my life,’ it is an unforgettable moment.” Read about laureates James P. Allison and Tasuku Honjo…
“When I meet patients who tell me: ‘You saved my life,’ it is an unforgettable moment.” Read about laureates James P. Allison and Tasuku Honjo…
MIT’s Bob Weinberg is perhaps the world’s most prominent cancer researcher. In this episode, Bob emphasizes that true innovation often comes from blending ideas
MYBL2 Drives Prostate Cancer Plasticity / Anjali V. Sheahan, Beatriz German, cancer, Cancer Research Communications, Deborah L Burkhart, Ellis Lab, Hannah E.
Phenotypic plasticity is a recognized mechanism driving therapeutic resistance in prostate cancer (PCa) patients. While underlying molecular causations driving phenotypic plasticity have been identified, therapeutic…
Less than 100 years ago, prostate cancer which attacks a gland that is part of the male sex organ, was seen as a death sentence…
“When I meet patients who tell me: ‘You saved my life,’ it is an unforgettable moment.” Read about laureates James P. Allison and Tasuku Honjo…
